Cerebral palsy and preterm birth: How far have we come?

Pediatric Health

Volumn 3, Issue 2, 2009, Pages 111-113

  Schendel, Diana E ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID; MAGNESIUM SULFATE;

ANTIBIOTIC THERAPY; BRAIN DEVELOPMENT; CAUSAL ATTRIBUTION; CEREBRAL PALSY; CHRONIC LUNG DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; EDITORIAL; FETUS MONITORING; FETUS RISK; HIGH RISK PATIENT; HUMAN; INFERTILITY THERAPY; INTRAUTERINE INFECTION; LUNG FUNCTION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUROPATHOLOGY; NEWBORN DEATH; NEWBORN MORBIDITY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; RISK FACTOR;

EID: 70349635466     PISSN: 17455111     EISSN: None     Source Type: Journal    
DOI: 10.2217/phe.09.6     Document Type: Editorial

References (22)

1. Robertson CMT, Watt M-J, Yasui Y: Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 297, 2733-2740 (2007).
2. Himmelmann K, Hagberg G, Beckung E, Hagberg B, Uvebrant P: The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1199. Acta Paediatrica 94, 287-294 (2005).
3. Platt MJ, Cans C, Johnson A et al.: Trends in cerebral palsy among infants of very low birthwight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study. Lancet 369, 43-50 (2007).
4. Wilson-Costello D, Friedman H, Minich N et al.: Improved neurodevelomental outcomes for extremely low birth weight infants in 2000-2002. Pediatrics 119, 37-45 (2007).
5. Tommiska V, Heinonen K, Lehtonen L et al.: No improvement in outcome of nationwide extremely low birth weight infant populations between 1996-1997 and 1999-2000. Pediatrics 119, 29-36 (2007).
6. Vincer MJ, Allen AC, Joseph KS, Stinson DA, Scott H, Wood E: Increasing prevalence of cerebral palsy among very preterm infants: a population-based study. Pediatrics 118, e1621-e1626 (2006).
7. Hvidtjørn D, Grove J, Schendel D et al.: Cerebral palsy in children born after in vitro fertilization: the role of preterm delivery - a population-based, cohort study. Pediatrics 118, 475-482 (2006).
8. Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk for preterm birth. Cochrane Database Syst. Rev. DOI: 10.1002/14651858.CD004454.pub2. (2006).
9. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D: Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst. Rev. DOI: 10.1002/ 14651858.CD004661.pub3. (2009).
10. Engle WA; Committee on Fetus and Newborn: Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 121, 419-432 (2008).
11. Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS: Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N. Engl. J. Med. 357, 1179-1189 (2007).
12. O'Shea TM, Washburn LK, Nixon PA, Goldstein DJ: Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age. Pediatrics 120, 594-602 (2007).
13. Kenyon S, Pike K, Jones DR, Marlow N, Salt A, Taylor DJ: Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 372, 1310-1318 (2008a).
14. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, Taylor DJ: Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 372, 1319-1327 (2008).
15. Althaus JE, Petersen SM, Fox HE, Holcroft CJ, Graham EM: Can electronic fetal monitoring identify preterm neonates with cerebral white matter injury? Obstet. Gynecol. 105, 458-465 (2005).
16. Sameshima H, Ikenoue T, Ikeda T, Kamitomo M, Ibara S: Association of nonreassuring fetal heart rate patterns and subsequent cerebral palsy in pregnancies with intrauterine bacterial infection. Am. J. Perinatol. 22,181-187 (2005).
17. Kent A, Lomas F, Hurrion E, Dahlstrom JE: Antenatal steroids may reduce adverse neurological outcome following choriomanionitis: neurodevelopmental outcome and chorioamnionitis in premature infants. J. Paediatr. Child Health 41, 186-190 (2005).
18. Martin CR, Van Marter LJ, Allred AN, Leviton A; for the Developmental Epidemiology Network: Antenatal glucocorticoids increase early total thyroxine levels in premature infants. Biol. Neonate 87, 273-280 (2005).
19. 2-isoprostanes. Ann. Neurol. 58, 108-120 (2005).
20. Gibson CS, MacLennan AH, Dekker GA et al.: Candidate genes and cerebral palsy: a population-based study. Pediatrics 122, 1079-1085 (2008).
21. Dördelmann M, Kerk J, Dressler F et al.: Interleukin-10 high producer allele and ultrasound-defined periventricular white matter abnormalities in preterm infants: a preliminary study. NeuroPediatrics 37, 130-136 (2006).
22. Gibson CS, MacLennan AH, Hague WM et al.; for the South Australian Cerebral Palsy Research Group: Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am. J. Obstet. Gynecol. 193, 1437.E1-1437.E12 (2005).